NCT03329365View on ClinicalTrials.gov

Paroxysmal Nocturnal Hemoglobinuria in ESUS & ETUS

Active, not recruitingOBSERVATIONAL
Enrollment

200

Participants

Timeline

Start Date

November 1, 2018

Primary Completion Date

March 29, 2023

Study Completion Date

March 29, 2025

Conditions
Paroxysmal Nocturnal HemoglobinuriaEmbolic Stroke of Undetermined SourceTransient Ischemic AttackCerebral Vein Thrombosis
Trial Locations (1)

N6A5A5

London Health Sciences Centre, London

Sponsors
All Listed Sponsors
collaborator

Alexion Pharmaceuticals, Inc.

INDUSTRY

lead

London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's

OTHER